Cereno Scientific gets FDA clearance for phase IIb PAH trial
Go back to Cereno Scientific gets FDA clearance for phase IIb PAH trial| BARNES GROUP, Inc. (NYSE: B) | Delayed: 43.10 -1.73 (3.86%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $44.83 | 52 Week High | $44.27 | |||
| Open | $43.42 | 52 Week Low | $30.07 | |||
| Day High | $44.52 | P/E | 32.90 | |||
| Day Low | $43.02 | EPS | $1.31 | |||
| Volume | 11,193,905 | |||||
